Argenx Se (ARGX) Stock Forecast & Price Target

Compare

645 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARGX Analyst Ratings

Strong Buy

21 Buy

1 Hold

0 Sell

Based on 22 analysts giving stock ratings to

Argenx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$793.84

▲(17.82%Upside)

Based on 22 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $793.84 with a high forecast of $1,070.00 and a low forecast of $699.00. The average price target represents a 17.82% change from the last price of $673.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"515":"$515","654":"$654","793":"$793","932":"$932","1071":"$1,071"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1070,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.07K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":793.84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$793.84</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":699,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$699.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[515,654,793,932,1071],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,673.8,704.276923076923,734.7538461538461,765.2307692307692,795.7076923076922,826.1846153846153,856.6615384615384,887.1384615384616,917.6153846153845,948.0923076923077,978.5692307692307,1009.0461538461539,1039.523076923077,{"y":1070,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,673.8,683.0338461538461,692.2676923076923,701.5015384615384,710.7353846153846,719.9692307692308,729.2030769230769,738.4369230769231,747.6707692307692,756.9046153846155,766.1384615384616,775.3723076923077,784.6061538461539,{"y":793.84,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,673.8,675.7384615384615,677.676923076923,679.6153846153845,681.5538461538462,683.4923076923077,685.4307692307692,687.3692307692307,689.3076923076923,691.2461538461538,693.1846153846154,695.123076923077,697.0615384615385,{"y":699,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":516.18,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":547.28,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":595.58,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":617.49,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":615,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":655.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":624.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,070

Average Price Target$793.84

Lowest Price Target$699.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$749

Buy

11.16%

Upside

Reiterated

08/01/25

Argenx Se's strong financial performance and earnings call highlight significant growth and innovation. However, technical analysis indicates potential overbought conditions, and operational inefficiencies and cash flow challenges pose risks. The valuation reflects moderate expectations, balancing growth prospects with current market sentiment.

Joon LeeTruist Financial

Truist Financial

―

Buy

―

Reiterated

08/01/25

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

Joel BeattyRobert W. Baird

Robert W. Baird

$680→$788

Buy

16.95%

Upside

Reiterated

08/01/25

Argenx price target raised to $788 from $680 at BairdArgenx price target raised to $788 from $680 at Baird

Derek ArchilaWells Fargo

Wells Fargo

$741→$756

Buy

12.20%

Upside

Reiterated

08/01/25

Argenx SE's Strong Q2 Performance and Positive Outlook Reinforce Buy RatingWe believe shares could trade up +10-15% on Vyvgart's 2Q revs of $949MM, particularly as buyside's bull case was $910-$920MM. This should help address investor growth/ pricing concerns—ARGX's growth story is intact.

Yaron WerberTD Cowen

TD Cowen

$761→$800

Buy

18.73%

Upside

Assigned

08/01/25

Argenx's Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion

Douglas TsaoH.C. Wainwright

H.C. Wainwright

$720→$774

Buy

14.87%

Upside

Reiterated

08/01/25

Argenx Se's Strong Market Position and Impressive Financial Performance Drive Buy Rating

Xian DengUBS

UBS

$710

Hold

5.37%

Upside

Reiterated

08/01/25

UBS Remains a Hold on Argenx Se (ARGX)

Gavin Clark-GartnerEvercore ISI

Evercore ISI

$750→$775

Buy

15.02%

Upside

Reiterated

08/01/25

Argenx price target raised to $775 from $750 at Evercore ISIArgenx price target raised to $775 from $750 at Evercore ISI

Sean LaamanMorgan Stanley

Morgan Stanley

$700→$768

Buy

13.98%

Upside

Reiterated

08/01/25

Argenx Se (ARGX) Gets a Buy from Morgan StanleyMorgan Stanley analyst Sean Laaman raised the price target on argenx SE (NASDAQ: ARGX) to $768.00 (from $700.00) while maintaining a Overweight rating.

Leland GershellOppenheimer

Oppenheimer

$708→$778

Buy

15.46%

Upside

Reiterated

08/01/25

Argenx price target raised to $778 from $708 at OppenheimerArgenx price target raised to $778 from $708 at Oppenheimer

George FarmerScotiabank

Scotiabank

$715→$796

Buy

18.14%

Upside

Reiterated

08/01/25

Scotiabank Sticks to Their Buy Rating for Argenx Se (ARGX)

Samantha SemenkowCiti

Citi

$803→$845

Buy

25.41%

Upside

Reiterated

08/01/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (NASDAQ: ARGX) and Humana (NYSE: HUM)We utilize a 0% terminal growth rate to account for anticipated pipeline expansion in future years. We then discount cash flows by 8.5% annually. Within our coverage, we utilize an 8-10% discount rate for companies that are commercial staged, with 8.5% reflecting a higher confidence in continued revenue growth vs. 10%.

Thomas SmithLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

07/31/25

Argenx Se: Strong Buy Rating Backed by Robust Financial Performance and Strategic Advancements

Myles MinterWilliam Blair

William Blair

―

Buy

―

Reiterated

07/31/25

Argenx's Strong Financial Performance and Growth Prospects Justify Buy Rating

Yatin SunejaGuggenheim

Guggenheim

$1,060→$1,070

Buy

58.80%

Upside

Reiterated

07/31/25

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Illumina (NASDAQ: ILMN)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$749

Buy

11.16%

Upside

Reiterated

08/01/25

Joon LeeTruist Financial

Truist Financial

―

Buy

―

Reiterated

08/01/25

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

Joel BeattyRobert W. Baird

Robert W. Baird

$680→$788

Buy

16.95%

Upside

Reiterated

08/01/25

Argenx price target raised to $788 from $680 at BairdArgenx price target raised to $788 from $680 at Baird

Derek ArchilaWells Fargo

Wells Fargo

$741→$756

Buy

12.20%

Upside

Reiterated

08/01/25

Yaron WerberTD Cowen

TD Cowen

$761→$800

Buy

18.73%

Upside

Assigned

08/01/25

Argenx's Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion

Douglas TsaoH.C. Wainwright

H.C. Wainwright

$720→$774

Buy

14.87%

Upside

Reiterated

08/01/25

Argenx Se's Strong Market Position and Impressive Financial Performance Drive Buy Rating

Xian DengUBS

UBS

$710

Hold

5.37%

Upside

Reiterated

08/01/25

UBS Remains a Hold on Argenx Se (ARGX)

Gavin Clark-GartnerEvercore ISI

Evercore ISI

$750→$775

Buy

15.02%

Upside

Reiterated

08/01/25

Argenx price target raised to $775 from $750 at Evercore ISIArgenx price target raised to $775 from $750 at Evercore ISI

Sean LaamanMorgan Stanley

Morgan Stanley

$700→$768

Buy

13.98%

Upside

Reiterated

08/01/25

Argenx Se (ARGX) Gets a Buy from Morgan StanleyMorgan Stanley analyst Sean Laaman raised the price target on argenx SE (NASDAQ: ARGX) to $768.00 (from $700.00) while maintaining a Overweight rating.

Leland GershellOppenheimer

Oppenheimer

$708→$778

Buy

15.46%

Upside

Reiterated

08/01/25

Argenx price target raised to $778 from $708 at OppenheimerArgenx price target raised to $778 from $708 at Oppenheimer

George FarmerScotiabank

Scotiabank

$715→$796

Buy

18.14%

Upside

Reiterated

08/01/25

Scotiabank Sticks to Their Buy Rating for Argenx Se (ARGX)

Samantha SemenkowCiti

Citi

$803→$845

Buy

25.41%

Upside

Reiterated

08/01/25

Thomas SmithLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

07/31/25

Argenx Se: Strong Buy Rating Backed by Robust Financial Performance and Strategic Advancements

Myles MinterWilliam Blair

William Blair

―

Buy

―

Reiterated

07/31/25

Argenx's Strong Financial Performance and Growth Prospects Justify Buy Rating

Yatin SunejaGuggenheim

Guggenheim

$1,060→$1,070

Buy

58.80%

Upside

Reiterated

07/31/25

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Illumina (NASDAQ: ILMN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

1 Month

xxx

Success Rate

15/22 ratings generated profit

Average Return

+4.52%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +4.52% per trade.

3 Months

xxx

Success Rate

23/32 ratings generated profit

Average Return

+15.49%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +15.49% per trade.

1 Year

Allison BratzelPiper Sandler

Success Rate

21/22 ratings generated profit

Average Return

+26.26%

reiterated a buy rating 6 days ago

Copying Allison Bratzel's trades and holding each position for 1 Year would result in 95.45% of your transactions generating a profit, with an average return of +26.26% per trade.

2 Years

xxx

Success Rate

32/32 ratings generated profit

Average Return

+79.29%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +79.29% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARGX has received 45 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 793.84.

Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $4.57 with a range of $3.28 to $6.72. The previous quarter’s EPS was $3.74. ARGX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.08% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $1.07B with a range of $927.00M to $1.17B. The previous quarter’s sales results were $1.75B. ARGX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.14% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?

Based on analyst ratings, Argenx Se’s 12-month average price target is 793.84.

What is ARGX’s upside potential, based on the analysts’ average price target?

Argenx Se has 17.82% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARGX a Buy, Sell or Hold?

Argenx Se has a consensus rating of Strong Buy which is based on 21 buy ratings, 1 hold ratings and 0 sell ratings.

What is Argenx Se’s price target?

The average price target for Argenx Se is 793.84. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,070.00 ,the lowest forecast is $699.00. The average price target represents 17.82% Increase from the current price of $673.8.

What do analysts say about Argenx Se?

Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of ARGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Argenx Se (ARGX) Stock Forecast & Price Target

ARGX Analyst Ratings

ARGX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Argenx Se

ARGX Analyst Recommendation Trends

ARGX Financial Forecast

ARGX Earnings Forecast

ARGX Sales Forecast

ARGX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts